Main Content start here
Main Layout
Report Description

Report Description

Argentina Glucometer market is anticipated to witness impressive growth during the forecast period. This can be attributed to the increasing need for easy-to-use devices for diabetes monitoring because it provides an immediate diagnosis result such as, used to measure the glucose concentration in a patient’s blood. The device uses a tiny drop of blood, which is usually obtained by prick of the finger using a lancet to read the blood glucose level.Also, increasing demand for easy and convenient testing along with growing demand for handy and easy to travel devices such as Care Touch, Metene, Auvon Blood, Keto-Mojo, Glucoracy, and CareSens are expected to create a lucrative growth of Argentina Glucometer market during the forecast period. The first glucometers were developed in the 1970s, but they did not become widely available until the 1980s. It is likely that glucometers became available in Argentina around this time, as they were already being used in other countries. Glucometers provide a quick and easy way for people with diabetes to check their blood glucose levels at home or on-the-go. This allows them to adjust their diet, exercise, and medication as needed to keep their blood glucose levels within a safe and healthy range. Glucometer also identify trends in blood glucose levels over time, which can help with long-term management of diabetes.

 

User-Friendliness Of Glucometer Accu-Chek Being a Significant Market Driver

 

The user-friendliness of glucometers has played a significant role in driving the growth of the Argentina glucometer market. The ease of use and convenience of these devices have made them accessible to a wider range of people with diabetes, including those who may have been hesitant to use traditional blood glucose monitoring methods. Modern glucometers are designed to be compact, portable, and easy to operate. Many of them come with features such as large screens, simple interfaces, and audio alerts that make them easier to use, especially for people who may have limited vision or dexterity. Some glucometers also offer wireless connectivity, allowing users to automatically transfer their data to mobile apps or cloud-based platforms. the increased awareness and education about diabetes, propels the growth of Argentina Glucometer Market The Argentine Diabetes Society (Sociedad Argentina de Diabetes) is a non-profit organization that works to promote diabetes awareness and education in the country. The importance of blood glucose monitoring has led to more people looking out for these devices. As a result, the demand for user-friendly and convenient glucometers has grown in Argentina, leading to increased sales and revenue for manufacturers. To track their blood sugar, more than two million Lain Americans with diabetes now use continuous glucose monitors, or CGMs. They assist those with Type 1 diabetes in administering the proper dosage of insulin, It’s a hormone they don’t produce yet but need in order to survive.

Increasing Prevalence of Diabetes Growing the Market

Diabetes is a chronic health condition that affects a significant number of people in Argentina, and the prevalence is projected to continue rising in the coming years. This has led to a growing demand for diabetes management devices like glucometers. According to the International Diabetes Federation (IDF), approximately 5.5 million people in Argentina have diabetes, which represents around 10.5% of the adult population. This makes diabetes a significant health concern in the country. More people need glucose monitoring devices like glucometers. This has driven the demand for these devices and has created opportunities for companies in the market. Additionally, as the number of people with diabetes grows, there is also an increased need for education and awareness about the condition, including the importance of regular blood glucose monitoring. In Latin America, more than 133 million people have diabetes or prediabetes. More than 10 million Latin Americans, or 31% of those with diagnosed diabetes, are receiving insulin treatment and could benefit from a continuous glucose monitor (CGM).

The increasing prevalence of diabetes has also led to an increase in healthcare spending in the country. Healthcare spending in Argentina accounts for approximately 9-10% of GDP, among the highest in the region. This has made it easier for people to access diabetes management devices like glucometers and has also created more opportunities for companies in the market to expand their product offerings and distribution networks. Overall, the increasing prevalence of diabetes is a key driver of the glucometer market in Argentina, and this trend is expected to continue the growth of Argentina Glucometer Market.

 

Rising Awareness about Diabetes

 

There has been an increasing awareness about diabetes and its management in Argentina, which has led to more people seeking out ways to monitor and manage their blood glucose levels. This has contributed to the demand for glucometers in the country. In Argentina, the prevalence of diabetes (in percent of the population aged 20 to 79 years) was 5.4% in 2021, as reported by the World Bank's collection of development indicators compiled from official sources. World Bank - Argentina - Diabetes prevalence (in percent of population aged 20-79 years) - actual figures, historical data, forecast and projections as of August, 2023.. Increased awareness about diabetes is being driven by various factors, including public health campaigns, educational programs, and media coverage. These efforts have helped to raise awareness about the importance of regular blood glucose monitoring and the potential risks associated with uncontrolled diabetes. The Argentina Ministry of Health runs various public health campaign throughout the year to raise awareness about Diabetes and its prevention. World Diabetes Day (November 14th) is a global campaign that the Ministry participates in, promoting messages about healthy living and the importance of regular blood glucose monitoring. There are various education programs available in Argentina aimed at educating people about diabetes management. These programs may be run by healthcare providers, diabetes associations, or patient advocacy groups. They may offer information about healthy eating, physical activity, blood glucose monitoring, and medication management. Media outlets in Argentina regularly cover stories related to diabetes, including updates on new treatments, research findings, and public health campaigns. This media coverage can help in raising awareness about the condition and its management among a wider audience. As a result of this increased awareness, more people in Argentina are recognizing the benefits of using a glucometer to monitor their blood glucose levels. This has led to greater demand for these devices, creating opportunities for companies in the market to expand their product offerings and distribution networks. Also, rising awareness about diabetes has also led to an increase in the number of people seeking medical treatment for the condition. This has led to an increase in healthcare spending, which has created more opportunities for companies in the market to expand their offerings and reach more customers.


Download Free Sample Report

Recent Developments

  • in 2020, LifeScan, a subsidiary of Johnson & Johnson, acquired the assets of Pulsar Vascular, a medical device company that develops and manufactures vascular access products. While this acquisition is not directly related to the glucometer market, it demonstrates the ongoing consolidation and expansion of medical device companies in the healthcare sector in Argentina.
  • in 2020, Roche introduced the Accu-Chek Guide, a new blood glucose monitoring system that comes with an app for tracking results and reminders for testing.

 

Market Segmentation

The Argentina Glucometer market can be segmented by Product Type, Technique, Distribution Channel, End User, and Region. Based on Product Type, the market can be segmented into Continuous Glucose Monitoring (CGM) system, Self-Monitoring Blood Glucose (SMBG) system. Based on Technique, the market can be segmented into Invasive, Non-Invasive. Based on Distribution Channel, the market can be grouped into Retail Pharmacies, Hospital Pharmacies, Online Sales. Based on End User, the market can be grouped into Individual with Diabetes, Hospitals, Clinics, Diagnostic Center.

 

Market Players

Roche  Diagnostics, Abbott Laboratories, LifeScan, Inc., Becton, Dickinson, & Co Ltd., Sanofi S.A., Johnson & Johnson Inc, Ascensia Diabetes Care Holdings AG, Terumo Corp, Ypsomed AG, Trividia Health, Inc/Argentina. are some of the leading players operating in the Argentina Glucometer market.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Product Type

Technique

Distribution Channel

End User

Regional scope

Pampas, Litoral, Northwest, Sierras and Cuyo

Key companies profiled

Roche Diagnostics, Abbott Laboratories, LifeScan, Inc., Becton, Dickinson, & Co Ltd., Sanofi S.A., Johnson & Johnson Inc, Ascensia Diabetes Care Holdings AG, Terumo Corp, Ypsomed AG, Trividia Health, Inc/Argentina.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, the Argentina Glucometer market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Argentina Glucometer Market, By Product Type:

o      Continuous Glucose Monitoring (CGM) System

o      Self-Monitoring Blood Glucose (SMBG) 

  • Argentina Glucometer Market, By Technique:

o      Invasive

o      Non-Invasive

  • Argentina Glucometer Market, By Distribution Channel:

o      Retail Pharmacies

o      Hospital Pharmacies

o      Online Sales

  • Argentina Glucometer Market, By End User:

o      Individual With Diabetes

o      Hospitals

o      Clinics

o      Diagnostics Centers

  • Argentina Glucometer Market, By Region:

o      Pampas

o      Litoral

o      Northwest

o      Sierras

o      Cuyo

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present Argentina Glucometer Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Argentina Glucometer Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Types

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, and Trends

4.    Voice of Customer

5.    Argentina Glucometer Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Product Type (Continuous Glucose Monitoring (CGM) Systems, Self-Monitoring Blood Glucose (SMBG) Systems)

5.2.2.    By Technique (Invasive, Non-Invasive)

5.2.3.    By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Sales.)

5.2.4.    By End User (Individuals with Diabetes, Hospitals, Clinics, and Diagnostic Centers)

5.2.5.    By Region

5.2.6.    By Company (2022)

5.3.  Market Map

6.    Argentina Continuous Glucose Monitoring (CGM) Systems Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Technique

6.2.2.    By Distribution Channel

6.2.3.    By End User

7.    Argentina Self-Monitoring Blood Glucose Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Technique

7.2.2.    By Distribution Channel

7.2.3.    By End User

8.    Market Dynamics

8.1.  Drivers

8.2.  Challenges

9.    Market Trends & Developments

9.1.  Merger & Acquisition

9.2.  Product Development

9.3.  Recent Developments

10. Policy & Regulatory Landscape

11. Porters Five Forces Analysis

11.1.             Competition in the Industry

11.2.             Potential of New Entrants

11.3.             Power of Suppliers

11.4.             Power of Customers

11.5.             Threat of Substitute Products

12. Argentina Economic Profile

13. Competitive Landscape

13.1.             Business Overview

13.2.             Company Snapshot

13.3.             Products & Services

13.4.             Financials (As Reported)

13.5.             Recent Developments

13.5.1. Roche Diagnostics

13.5.2. Abbott Laboratories

13.5.3. LifeScan, Inc.

13.5.4. Becton, Dickinson, & Co Ltd.

13.5.5. Sanofi S.A.

13.5.6. Johnson & Johnson Inc

13.5.7. Ascensia Diabetes Care Holdings AG

13.5.8. Terumo Corp

13.5.9. Ypsomed AG

13.5.10.              Trividia Health, Inc/Argentina

14. Strategic Recommendations

About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The development of user-friendly products and increasing prevalence of diabetes across the region are some of the major factors driving the growth of the Argentina Glucometer market.

Roche Diagnostics, Abbott Laboratories, LifeScan, Inc., Becton, Dickinson, & Co Ltd., Sanofi S.A., Johnson & Johnson Inc, Ascensia Diabetes Care Holdings AG, Terumo Corp, Ypsomed AG, Trividia Health, Inc/Argentina. are some of the leading players operating in the Canada Dietary Supplements Market.

The Non-Invasive technique is expected to dominate the Argentina glucometer market during the forecast period because non-invasive glucometers use technology that does not require a blood sample for glucose testing.

The cost of glucometer, lack of awareness, competition and regulatory barriers are the major challenges in the Argentina glucometer market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.